Lillian Siu

{{Short description|Canadian oncologist and physician-scientist}}

{{Orphan|date=March 2024}}

{{Infobox scientist

| name = Lillian Siu

| fields = Oncology

| workplaces = University of Toronto
Princess Margaret Cancer Centre

| alma_mater = University of Toronto

}}

Lillian Lai Yun Siu is a Canadian oncologist and physician-scientist who researches anticancer drug development. She is a professor of medicine at the University of Toronto and a senior medical oncologist at the Princess Margaret Cancer Centre.

Life

Siu earned a M.D. from the University of Toronto Faculty of Medicine.{{Cite web |date=March 19, 2024 |title=Lillian Siu Named 2024–2025 AACR President Elect |url=https://ascopost.com/news/march-2024/lillian-siu-named-2024-2025-aacr-president-elect/ |access-date=2024-03-23 |website=The ASCO Post |language=en}} She completed an oncopharmacology fellowship at the Princess Margaret Cancer Centre and a clinical research fellowship in new drug development at the University of Texas Health Science Center at San Antonio.

Siu researches anticancer drug development. She has served as a professor of medicine at the University of Toronto Faculty of Medicine since 2009 and a senior medical oncologist at the Princess Margaret Cancer Centre since 1998.{{Cite web |title=Lillian L Siu {{!}} UHN Research |url=https://www.uhnresearch.ca/researcher/lillian-l-siu |access-date=2024-03-23 |website=www.uhnresearch.ca}} Siu is an elected fellow of the American Society of Clinical Oncology (2015), Canadian Academy of Health Sciences (2023), and the American Association for Cancer Research (AACR). She became the editor-in-chief of Cancer Research Communications in 2021. In 2024, Siu was selected as the president-elect of the AACR.

References